Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Osawa, Kazuhiro ^a   Miyoshi, Toru ^a   Yamauchi, Kentarou ^b   Koyama, Yasushi ^c   Nakamura, Kazufumi ^a   Sato, Shuhei ^a   Kanazawa, Susumu ^a   Ito, Hiroshi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^c Sakurabashi Watanabe Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; FEMALE; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONALCOHOLIC FATTY LIVER; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; AGED; CASE CONTROL STUDY; COMPLICATION; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PROCEDURES;

AGED; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; MULTIDETECTOR COMPUTED TOMOGRAPHY; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; PLAQUE, ATHEROSCLEROTIC; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84938674429     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131138     Document Type: Article

References (40)

1. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. (2004) Prevalence of hepatic steatosis in an urban population in the united states: Impact of ethnicity. Hepatology 40:1387-1395 PMID: 15565570
2. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363:1341-1350 doi: 10.1056/NEJMra0912063 PMID: 20879883
3. Kim D, Choi SY, Park EH, Lee W, Kang JH, Kim W, et al. (2012) Nonalcoholic fatty liver disease is associated with coronary artery calcification. Hepatology 56:605-613 doi: 10.1002/hep.25593 PMID: 22271511
4. Akabame S, Hamaguchi M, Tomiyasu K, Tanaka M, Kobayashi-Takenaka Y, Nakano K, et al. (2008) Evaluation of vulnerable coronary plaques and non-alcoholic fatty liver disease (nafld) by 64-detector multislice computed tomography (msct). Circ J 72:618-625 PMID: 18362435
5. Lonardo A, Ballestri S, Targher G, Loria P (2015) Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol 9:629-650 doi: 10.1586/17474124.2015.965143 PMID: 25327387
6. Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G (2014) Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease. World J Gastroenterol 20:1724-1745 doi: 10.3748/wjg.v20.i7.1724 PMID: 24587651
7. Anstee QM, Targher G, Day CP (2013) Progression of nafld to diabetes mellitus, cardiovascular disease or cirrhosis. Nat Rev Gastroenterol Hepatol 10:330-344 doi: 10.1038/nrgastro.2013.41 PMID: 23507799
8. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: A spectrum of clinical and pathological severity. Gastroenterology 116:1413-1419 PMID: 10348825
9. Ma X, Holalkere NS, Kambadakone RA, Mino-Kenudson M, Hahn PF, Sahani DV (2009) Imaging-based quantification of hepatic fat: Methods and clinical applications. Radiographics 29:1253-1277 doi: 10.1148/rg.295085186 PMID: 19755595
10. Zeb I, Li D, Nasir K, Katz R, Larijani VN, Budoff MJ (2012) Computed tomography scans in the evaluation of fatty liver disease in a population based study: The multi-ethnic study of atherosclerosis. Acad Radiol 19:811-818 doi: 10.1016/j.acra.2012.02.022 PMID: 22521729
11. Osawa K, Miyoshi T, Koyama Y, Sato S, Akagi N, Morimitsu Y, et al. (2014) Differential association of visceral adipose tissue with coronary plaque characteristics in patients with and without diabetes mellitus. Cardiovasc Diabetol 13:61 doi: 10.1186/1475-2840-13-61 PMID: 24624968
12. Assy N, Djibre A, Farah R, Grosovski M, Marmor A (2010) Presence of coronary plaques in patients with nonalcoholic fatty liver disease. Radiology 254:393-400 doi: 10.1148/radiol.09090769 PMID: 20093511
13. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. (2010) Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The framingham heart study. Hepatology 51:1979-1987 doi: 10.1002/hep.23593 PMID: 20336705
14. Osawa K, Miyoshi T, Sato S, Akagi N, Morimitsu Y, Nakamura K, et al. (2013) Safety and efficacy of a bolus injection of landiolol hydrochloride as a premedication for multidetector-row computed tomography coronary angiography. Circ J 77:146-152 PMID: 23037522
15. Osawa K, Miyoshi T, Koyama Y, Hashimoto K, Sato S, Nakamura K, et al. (2014) Additional diagnostic value of first-pass myocardial perfusion imaging without stress when combined with 64-row detector coronary ct angiography in patients with coronary artery disease. Heart
16. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. (2002) Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the cardiac imaging committee of the council on clinical cardiology of the american heart association. Int J Cardiovasc Imaging 18:539-542 PMID: 12135124
17. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. (2005) Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 42:473-480 PMID: 15981216
18. Brea A, Mosquera D, Martin E, Arizti A, Cordero JL, Ros E (2005) Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: A case-control study. Arterioscler Thromb Vasc Biol 25:1045-1050 PMID: 15731489
19. Wong VW, Wong GL, Yip GW, Lo AO, Limquiaco J, Chu WC, et al. (2011) Coronary artery disease and cardiovascular outcomes in patients with non-alcoholic fatty liver disease. Gut 60:1721-1727 doi: 10.1136/gut.2011.242016 PMID: 21602530
20. Mellinger JL, Pencina KM, Massaro JM, Hoffmann U, Seshadri S, Fox CS, et al. (2015) Hepatic steatosis and cardiovascular disease outcomes: An analysis of the framingham heart study. J Hepatol
21. Targher G, Byrne CD (2013) Diagnosis and management of nonalcoholic fatty liver disease and its hemostatic/thrombotic and vascular complications. Semin Thromb Hemost 39:214-228 doi: 10.1055/s-0033-1334866 PMID: 23397556
22. Byrne CD, Targher G (2014) Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: Implications for cardiovascular disease. Arterioscler Thromb Vasc Biol 34:1155-1161 doi: 10.1161/ATVBAHA.114.303034 PMID: 24743428
23. Petta S, Argano C, Colomba D, Camma C, Di Marco V, Cabibi D, et al. (2015) Epicardial fat, cardiac geometry and cardiac function in patients with non-alcoholic fatty liver disease: Association with the severity of liver disease. J Hepatol 62:928-933 doi: 10.1016/j.jhep.2014.11.030 PMID: 25445395
24. Petta S, Torres D, Fazio G, Camma C, Cabibi D, Di Marco V, et al. (2012) Carotid atherosclerosis and chronic hepatitis c: A prospective study of risk associations. Hepatology 55:1317-1323 doi: 10.1002/hep.25508 PMID: 22135089
25. Adinolfi LE, Zampino R, Restivo L, Lonardo A, Guerrera B, Marrone A, et al. (2014) Chronic hepatitis c virus infection and atherosclerosis: Clinical impact and mechanisms. World J Gastroenterol 20:3410-3417 doi: 10.3748/wjg.v20.i13.3410 PMID: 24707124
26. Loria P, Marchesini G, Nascimbeni F, Ballestri S, Maurantonio M, Carubbi F, et al. (2014) Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. Atherosclerosis 232:99-109 doi: 10.1016/j.atherosclerosis.2013.10.030 PMID: 24401223
27. Puchner SB, Lu MT, Mayrhofer T, Liu T, Pursnani A, Ghoshhajra BB, et al. (2015) High-risk coronary plaque at coronary ct angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: Results from the romicat ii trial. Radiology 274:693-701 doi: 10.1148/radiol.14140933 PMID: 25369449
28. Fabbrini E, Sullivan S, Klein S (2010) Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications. Hepatology 51:679-689 doi: 10.1002/hep.23280 PMID: 20041406
29. Targher G, Bertolini L, Scala L, Zoppini G, Zenari L, Falezza G (2005) Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue. Diabet Med 22:1354-1358 PMID: 16176196
30. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415-1428 PMID: 15836891
31. Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Siren J, Hamsten A, et al. (2007) Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects. Diabetes 56:2759-2765 PMID: 17704301
32. Ballestri S, Meschiari E, Baldelli E, Musumeci FE, Romagnoli D, Trenti T, et al. (2013) Relationship of serum fetuin-a levels with coronary atherosclerotic burden and nafld in patients undergoing elective coronary angiography. Metab Syndr Relat Disord 11:289-295 doi: 10.1089/met.2012.0149 PMID: 23600632
33. Hamaguchi M, Kojima T, Takeda N, Nagata C, Takeda J, Sarui H, et al. (2007) Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol 13:1579-1584 PMID: 17461452
34. Haring R, Wallaschofski H, Nauck M, Dorr M, Baumeister SE, Volzke H (2009) Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels. Hepatology 50:1403-1411 doi: 10.1002/hep.23135 PMID: 19670414
35. Jepsen P, Vilstrup H, Mellemkjaer L, Thulstrup AM, Olsen JH, Baron JA, et al. (2003) Prognosis of patients with a diagnosis of fatty liver - a registry-based cohort study. Hepatogastroenterology 50:2101-2104 PMID: 14696473
36. Kitagawa T, Yamamoto H, Horiguchi J, Ohhashi N, Tadehara F, Shokawa T, et al. (2009) Characterization of noncalcified coronary plaques and identification of culprit lesions in patients with acute coronary syndrome by 64-slice computed tomography. JACC Cardiovasc Imaging 2:153-160 doi: 10.1016/j.jcmg.2008.09.015 PMID: 19356549
37. Motoyama S, Sarai M, Harigaya H, Anno H, Inoue K, Hara T, et al. (2009) Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol 54:49-57 doi: 10.1016/j.jacc.2009.02.068 PMID: 19555840
38. Rana JS, Dunning A, Achenbach S, Al-Mallah M, Budoff MJ, Cademartiri F, et al. (2012) Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: Results from 10,110 individuals from the confirm (coronary ct angiography evaluation for clinical outcomes): An international multicenter registry. Diabetes Care 35:1787-1794 doi: 10.2337/dc11-2403 PMID: 22699296
39. Ballestri S, Romagnoli D, Nascimbeni F, Francica G, Lonardo A (2015) Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications. Expert Rev Gastroenterol Hepatol 9:603-627 doi: 10.1586/17474124.2015.1007955 PMID: 25694178
40. Park SH, Kim PN, Kim KW, Lee SW, Yoon SE, Park SW, et al. (2006) Macrovesicular hepatic steatosis in living liver donors: Use of ct for quantitative and qualitative assessment. Radiology 239:105-112 PMID: 16484355